Cardiovascular disease is often thought of as a condition that primarily affects men, but it’s the leading cause of death in women too, and a woman’s risk changes significantly around menopause. Much of this shift is linked to oestrogen, which has a protective effect on the cardiovascular system throughout a woman’s reproductive years. Lifestyle factors compound this risk further, as explored in our article on depression, sedentary living, and their impact on heart and brain health.
This guide explains how oestrogen supports cardiovascular health, why risk changes after menopause, what the evidence says about HRT and heart disease, and why timing is central to understanding that evidence.
How Oestrogen Supports Cardiovascular Health
Oestrogen has several protective effects on the cardiovascular system. It helps maintain the flexibility of blood vessel walls, supports healthy cholesterol profiles by raising HDL (“good”) cholesterol and lowering LDL (“bad”) cholesterol, and has anti-inflammatory properties that benefit blood vessel function. Together, these effects are thought to explain why premenopausal women generally have a lower risk of cardiovascular disease than men of the same age.
Why Risk Changes After Menopause
As oestrogen declines during and after menopause, its protective effects on blood vessels and cholesterol gradually diminish. Within about ten years of menopause, women’s cardiovascular risk rises to approach that of men, and cardiovascular disease becomes the leading cause of death in postmenopausal women.
Menopause and Cardiovascular Disease Risk
Beyond the direct loss of oestrogen’s vascular effects, menopause is often accompanied by other changes that compound cardiovascular risk: shifts in body fat distribution toward the abdomen, changes in insulin sensitivity, and increases in blood pressure. These changes don’t happen to every woman, but they’re common enough that menopause is now recognised as an important checkpoint for reassessing cardiovascular risk factors.
Risk Factors Worth Monitoring Around Menopause
- Blood pressure, which can rise during the menopause transition
- Cholesterol levels, particularly LDL and triglycerides
- Blood sugar and insulin resistance markers
- Weight and body fat distribution
- Smoking status, which compounds cardiovascular risk significantly
HRT and Heart Disease Risk: The Timing Hypothesis
The relationship between HRT and cardiovascular risk is one of the most debated areas in menopause medicine, largely because early research produced results that seemed to conflict with what was previously understood about oestrogen’s protective effects. The explanation that has since emerged is known as the timing hypothesis: HRT started within about ten years of menopause, or before age 60, appears to be cardiovascular-neutral or even protective for many women, while starting HRT much later in life, in women who may already have established atherosclerosis, has been associated with a different, less favourable risk profile.
Why Timing Matters So Much
Oestrogen appears to help maintain healthy blood vessels but may not reverse damage in vessels that have already developed significant plaque. This is thought to explain why the same hormone can appear protective in one context and higher-risk in another, depending entirely on when treatment begins relative to the menopause transition.
Transdermal Oestrogen and Heart and Stroke Risk
The route by which oestrogen is delivered also appears to matter for cardiovascular and stroke risk. Transdermal oestrogen, delivered through patches or gels, bypasses first-pass liver metabolism and has been associated with a lower risk of blood clots and stroke compared with oral oestrogen in several studies. This is one of several factors a specialist will consider when discussing which type of HRT may be most appropriate for an individual woman’s cardiovascular risk profile.
Who Should Be Particularly Cautious
Certain women warrant closer discussion before starting HRT, including those with a personal history of blood clots, stroke, or heart disease, uncontrolled high blood pressure, or a strong family history of early cardiovascular disease. This doesn’t necessarily rule out HRT, but it does mean the decision benefits from an individualised risk assessment rather than a generic recommendation.
Supporting Heart Health Through Menopause
Alongside any decisions about HRT, several lifestyle measures meaningfully support cardiovascular health during and after menopause: regular aerobic exercise, a heart-healthy diet, maintaining a healthy weight, not smoking, and managing blood pressure and cholesterol. These measures matter for every woman at this life stage, regardless of whether HRT is part of the plan.
Heart Health as Part of a Broader Care Plan
Our approach to green gynaecology considers lifestyle and long-term wellbeing alongside conventional care, and our team can help you weigh up your individual cardiovascular risk factors when discussing HRT and other menopause management options.
Conclusion
Oestrogen has a real, biologically grounded protective effect on the cardiovascular system, and its decline during menopause is an important reason why heart disease risk rises in the years that follow. The relationship between HRT and cardiovascular risk depends heavily on timing and individual risk factors, which is why this decision is best discussed with a menopause specialist rather than approached as a one-size-fits-all recommendation.
If you’d like to discuss your cardiovascular risk and HRT options, book a consultation with our clinic.
Frequently Asked Questions
Does HRT increase my risk of a heart attack?
For most women who start HRT within ten years of menopause or before age 60, current evidence doesn’t show an increased heart attack risk, and some studies suggest a protective effect. Risk profiles differ for women starting HRT later or with existing cardiovascular disease.
Is transdermal HRT safer for the heart than tablets?
Transdermal oestrogen has been associated with a lower risk of blood clots and stroke compared with oral oestrogen in several studies, which is one factor your clinician may consider when discussing options with you.
Can I take HRT if I have a family history of heart disease?
A family history doesn’t automatically rule out HRT, but it’s an important factor in your individual risk assessment and should be discussed in detail with your gynaecologist.
Does menopause itself cause heart disease?
Menopause doesn’t directly cause heart disease, but the loss of oestrogen’s protective effects, combined with other age-related changes, contributes to rising cardiovascular risk in postmenopausal women.
What’s the single most important thing I can do for heart health at menopause?
There isn’t one single measure, but regular cardiovascular exercise, not smoking, and having your blood pressure and cholesterol checked are consistently among the most impactful steps women can take at this stage.